GILT expression in B cells diminishes cathepsin S steady-state protein expression and activity

Hannah Phipps-Yonas, Vikki Semik, Karen Taraszka Hastings

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

MHC class II-restricted Ag processing requires protein degradation in the endocytic pathway for the activation of CD4+ T cells. Gamma-interferon-inducible lysosomal thiol reductase (GILT) facilitates Ag processing by reducing protein disulfide bonds in this compartment. Lysosomal cysteine protease cathepsin S (CatS) contains disulfide bonds and mediates essential steps in MHC class II-restricted processing, including proteolysis of large polypeptides and cleavage of the invariant chain. We sought to determine whether GILT's reductase activity regulates CatS expression and function. Confocal microscopy confirmed that GILT and CatS colocalized within lysosomes of B cells. GILT expression posttranscriptionally decreased the steady-state protein expression of CatS in primary B cells and B-cell lines. GILT did not substantially alter the expression of other lysosomal proteins, including H2-M, H2-O, or CatL. GILT's reductase active site was necessary for diminished CatS protein levels, and GILT expression decreased the half-life of CatS, suggesting that GILT-mediated reduction of protein disulfide bonds enhances CatS degradation. GILT expression decreased the proteolysis of a CatS selective substrate. This study illustrates a physiologic mechanism that regulates CatS and has implications for fine tuning MHC class II-restricted Ag processing and for the development of CatS inhibitors, which are under investigation for the treatment of autoimmune disease.

Original languageEnglish (US)
Pages (from-to)65-74
Number of pages10
JournalEuropean Journal of Immunology
Volume43
Issue number1
DOIs
StatePublished - Jan 2013

Fingerprint

cathepsin S
Sulfhydryl Compounds
Interferon-gamma
Oxidoreductases
Cats
B-Lymphocytes
Proteins
Disulfides
Proteolysis

Keywords

  • Antigen presentation/processing
  • Antigen presenting cells
  • B cells
  • Cathepsin S
  • Gamma-interferon-inducible lysosomal thiol reductase (GILT)

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

GILT expression in B cells diminishes cathepsin S steady-state protein expression and activity. / Phipps-Yonas, Hannah; Semik, Vikki; Hastings, Karen Taraszka.

In: European Journal of Immunology, Vol. 43, No. 1, 01.2013, p. 65-74.

Research output: Contribution to journalArticle

@article{65d0c438958d4adaa5d8953f1c358eff,
title = "GILT expression in B cells diminishes cathepsin S steady-state protein expression and activity",
abstract = "MHC class II-restricted Ag processing requires protein degradation in the endocytic pathway for the activation of CD4+ T cells. Gamma-interferon-inducible lysosomal thiol reductase (GILT) facilitates Ag processing by reducing protein disulfide bonds in this compartment. Lysosomal cysteine protease cathepsin S (CatS) contains disulfide bonds and mediates essential steps in MHC class II-restricted processing, including proteolysis of large polypeptides and cleavage of the invariant chain. We sought to determine whether GILT's reductase activity regulates CatS expression and function. Confocal microscopy confirmed that GILT and CatS colocalized within lysosomes of B cells. GILT expression posttranscriptionally decreased the steady-state protein expression of CatS in primary B cells and B-cell lines. GILT did not substantially alter the expression of other lysosomal proteins, including H2-M, H2-O, or CatL. GILT's reductase active site was necessary for diminished CatS protein levels, and GILT expression decreased the half-life of CatS, suggesting that GILT-mediated reduction of protein disulfide bonds enhances CatS degradation. GILT expression decreased the proteolysis of a CatS selective substrate. This study illustrates a physiologic mechanism that regulates CatS and has implications for fine tuning MHC class II-restricted Ag processing and for the development of CatS inhibitors, which are under investigation for the treatment of autoimmune disease.",
keywords = "Antigen presentation/processing, Antigen presenting cells, B cells, Cathepsin S, Gamma-interferon-inducible lysosomal thiol reductase (GILT)",
author = "Hannah Phipps-Yonas and Vikki Semik and Hastings, {Karen Taraszka}",
year = "2013",
month = "1",
doi = "10.1002/eji.201242379",
language = "English (US)",
volume = "43",
pages = "65--74",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag",
number = "1",

}

TY - JOUR

T1 - GILT expression in B cells diminishes cathepsin S steady-state protein expression and activity

AU - Phipps-Yonas, Hannah

AU - Semik, Vikki

AU - Hastings, Karen Taraszka

PY - 2013/1

Y1 - 2013/1

N2 - MHC class II-restricted Ag processing requires protein degradation in the endocytic pathway for the activation of CD4+ T cells. Gamma-interferon-inducible lysosomal thiol reductase (GILT) facilitates Ag processing by reducing protein disulfide bonds in this compartment. Lysosomal cysteine protease cathepsin S (CatS) contains disulfide bonds and mediates essential steps in MHC class II-restricted processing, including proteolysis of large polypeptides and cleavage of the invariant chain. We sought to determine whether GILT's reductase activity regulates CatS expression and function. Confocal microscopy confirmed that GILT and CatS colocalized within lysosomes of B cells. GILT expression posttranscriptionally decreased the steady-state protein expression of CatS in primary B cells and B-cell lines. GILT did not substantially alter the expression of other lysosomal proteins, including H2-M, H2-O, or CatL. GILT's reductase active site was necessary for diminished CatS protein levels, and GILT expression decreased the half-life of CatS, suggesting that GILT-mediated reduction of protein disulfide bonds enhances CatS degradation. GILT expression decreased the proteolysis of a CatS selective substrate. This study illustrates a physiologic mechanism that regulates CatS and has implications for fine tuning MHC class II-restricted Ag processing and for the development of CatS inhibitors, which are under investigation for the treatment of autoimmune disease.

AB - MHC class II-restricted Ag processing requires protein degradation in the endocytic pathway for the activation of CD4+ T cells. Gamma-interferon-inducible lysosomal thiol reductase (GILT) facilitates Ag processing by reducing protein disulfide bonds in this compartment. Lysosomal cysteine protease cathepsin S (CatS) contains disulfide bonds and mediates essential steps in MHC class II-restricted processing, including proteolysis of large polypeptides and cleavage of the invariant chain. We sought to determine whether GILT's reductase activity regulates CatS expression and function. Confocal microscopy confirmed that GILT and CatS colocalized within lysosomes of B cells. GILT expression posttranscriptionally decreased the steady-state protein expression of CatS in primary B cells and B-cell lines. GILT did not substantially alter the expression of other lysosomal proteins, including H2-M, H2-O, or CatL. GILT's reductase active site was necessary for diminished CatS protein levels, and GILT expression decreased the half-life of CatS, suggesting that GILT-mediated reduction of protein disulfide bonds enhances CatS degradation. GILT expression decreased the proteolysis of a CatS selective substrate. This study illustrates a physiologic mechanism that regulates CatS and has implications for fine tuning MHC class II-restricted Ag processing and for the development of CatS inhibitors, which are under investigation for the treatment of autoimmune disease.

KW - Antigen presentation/processing

KW - Antigen presenting cells

KW - B cells

KW - Cathepsin S

KW - Gamma-interferon-inducible lysosomal thiol reductase (GILT)

UR - http://www.scopus.com/inward/record.url?scp=84872498812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872498812&partnerID=8YFLogxK

U2 - 10.1002/eji.201242379

DO - 10.1002/eji.201242379

M3 - Article

C2 - 23012103

AN - SCOPUS:84872498812

VL - 43

SP - 65

EP - 74

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 1

ER -